Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
ABSTRACTThe newly identified 2019 novel coronavirus (2019-nCoV) has caused more than 11,900 laboratory-confirmed human infections, including 259 deaths, posing a serious threat to human health. Currently, however, there is no specific antiviral treatment or vaccine. Considering the relatively high i...
Guardat en:
| Autors principals: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis Group
2020-01-01
|
| Col·lecció: | Emerging Microbes and Infections |
| Matèries: | |
| Accés en línia: | https://www.tandfonline.com/doi/10.1080/22221751.2020.1729069 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|